0001567619-20-014338.txt : 20200805
0001567619-20-014338.hdr.sgml : 20200805
20200805170226
ACCESSION NUMBER: 0001567619-20-014338
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200805
DATE AS OF CHANGE: 20200805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burnett Patrick
CENTRAL INDEX KEY: 0001741987
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39186
FILM NUMBER: 201078431
MAIL ADDRESS:
STREET 1: C/O VERRICA PHARMACEUTICALS INC.
STREET 2: 10 NORTH HIGH STREET, SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcutis Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001787306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812974255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2945 TOWNSGATE ROAD
STREET 2: SUITE 110
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
BUSINESS PHONE: 805-418-5006
MAIL ADDRESS:
STREET 1: 2945 TOWNSGATE ROAD
STREET 2: SUITE 110
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
FORMER COMPANY:
FORMER CONFORMED NAME: Arcutis, Inc.
DATE OF NAME CHANGE: 20190905
4
1
doc1.xml
FORM 4
X0306
4
2020-08-03
0
0001787306
Arcutis Biotherapeutics, Inc.
ARQT
0001741987
Burnett Patrick
C/O ARCUTIS BIOTHERAPEUTICS, INC.
2945 TOWNSGATE ROAD SUITE 110
WESTLAKE VILLAGE
CA
91361
0
1
0
0
See Remarks
Common Stock
2020-08-03
4
A
0
33500
0
A
33500
D
Stock Option (Right to Buy)
25.89
2020-08-03
4
A
0
320000
0.00
A
2030-08-03
Common Stock
320000
320000
D
Grant of Restricted Stock Units ("RSU"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
Includes 33,500 RSUs. The RSUs will begin vesting upon the achievement of the performance-based milestones.
The option vests as to 1/4 of the total shares on August 1, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested on August 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Senior Vice President and Chief Medical Officer
/s/ John W. Smither, as Attorney-in-Fact for Patrick Burnett
2020-08-05